Recall: D-0564-2024

Class II - Potentially Harmful

Class IIClassification

2024-05-20Initiated

OngoingStatus

Pfizer Inc.Firm

Product

Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03

Reason

Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Distribution

US Nationwide and Puerto Rico.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.